View printer-friendly version
« Back
January 08, 2015 8:00 a.m.
Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Jan. 8, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the 33rd Annual J.P. Morgan Healthcare Conference. Erez Vigodman, President & CEO will present on Tuesday, January 13, 2015 at 3:30 PM PST.

What:

    Teva Presentation at the 33rd Annual J.P. Morgan Healthcare Conference
 

Who:

Erez Vigodman, President & CEO,
Teva Pharmaceutical Industries Ltd.
 

When:

Tuesday, January 13, 2015
 

Where:

www.tevapharm.com

 

How:

Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.
 

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory, oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
IR:
United States:
Kevin C. Mannix, 215-591-8912
Ran Meir, 215-591-3033
or
Israel:
Tomer Amitai, 972 (3) 926-7656
or
PR:
Israel:
Iris Beck Codner, 972 (3) 926-7246
or
United States:
Denise Bradley, 215-591-8974